Fingerprint
Dive into the research topics of 'Treatment of Previously Treated Metastatic Breast Cancer by Mitoxantrone and 48-hour Continuous Infusion of High-dose 5-FU and Leucovorin (MFL): Low Palliative Benefit and High Treatment-related Toxicity'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically